UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 655

Sortiert nach

Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis

Clinical infectious diseases, 2017-06, Vol.64 (12), p.1670-1677

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

American journal of respiratory and critical care medicine, 2019-11, Vol.200 (10), p.e93-e142

2019

Link zum Volltext

Verfügbarkeit prüfen

Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States

Emerging infectious diseases, 2023-10, Vol.29 (10), p.2102-2104

2023

Link zum Volltext

Verfügbarkeit prüfen

Rifampin-resistant Tuberculosis in the United States, 1998–2014

Clinical infectious diseases, 2020-04, Vol.70 (8), p.1596-1605

2020

Link zum Volltext

Verfügbarkeit prüfen

State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity

PloS one, 2021-04, Vol.16 (4), p.e0249012-e0249012

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007

Emerging infectious diseases, 2014-05, Vol.20 (5), p.812-821

2014

Link zum Volltext

Verfügbarkeit prüfen

Treatment of latent Mycobacterium tuberculosis infection with 12 once weekly directly-observed doses of isoniazid and rifapentine among persons experiencing homelessness

PloS one, 2019-03, Vol.14 (3), p.e0213524-e0213524

2019

Link zum Volltext

Verfügbarkeit prüfen

Outlook for tuberculosis elimination in California: An individual-based stochastic model

PloS one, 2019-04, Vol.14 (4), p.e0214532-e0214532

2019

Link zum Volltext

Verfügbarkeit prüfen

Model-based Analysis of Tuberculosis Genotype Clusters in the United States Reveals High Degree of Heterogeneity in Transmission and State-level Differences Across California, Florida, New York, and Texas

Clinical infectious diseases, 2022-10, Vol.75 (8), p.1433-1441

2022

Link zum Volltext

Verfügbarkeit prüfen

Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model

American journal of epidemiology, 2018-09, Vol.187 (9), p.2011-2020

2018

Link zum Volltext

Verfügbarkeit prüfen

Healthcare facility-based strategies to improve tuberculosis testing and linkage to care in non-U.S.-born population in the United States: A systematic review

PloS one, 2019-09, Vol.14 (9), p.e0223077-e0223077

2019

Link zum Volltext

Verfügbarkeit prüfen

Trends, Mechanisms, and Racial/Ethnic Differences of Tuberculosis Incidence in the US-Born Population Aged 50 Years or Older in the United States

Clinical infectious diseases, 2022-05, Vol.74 (9), p.1594-1603

2022

Link zum Volltext

Verfügbarkeit prüfen

Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis

The Lancet (British edition), 2020-08, Vol.396 (10248), p.402-411

2020

Link zum Volltext

Verfügbarkeit prüfen

Yield of community-based tuberculosis targeted testing and treatment in foreign-born populations in the United States: A systematic review

PloS one, 2017-08, Vol.12 (8), p.e0180707-e0180707

2017

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model

JAMA internal medicine, 2017-12, Vol.177 (12), p.1755

2017

Link zum Volltext

Verfügbarkeit prüfen

Eligibility for a Shorter Treatment Regimen for Multidrug-resistant Tuberculosis in the United States, 2011–2016

Clinical infectious diseases, 2020-02, Vol.70 (5), p.907-916

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparing Drivers and Dynamics of Tuberculosis in California, Florida, New York, and Texas

American journal of respiratory and critical care medicine, 2017-10, Vol.196 (8), p.1050-1059

2017

Link zum Volltext

Verfügbarkeit prüfen

Time Since Infection and Risks of Future Disease for Individuals with Mycobacterium tuberculosis Infection in the United States

Epidemiology (Cambridge, Mass.), 2021-01, Vol.32 (1), p.70

2021

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States

Emerging infectious diseases, 2023-10, Vol.29 (10), p.2016-2023

2023

Link zum Volltext

Verfügbarkeit prüfen

Multidrug-Resistant Tuberculosis in Patients with Human Immunodeficiency Virus. Management Considerations within High-resourced Settings

Annals of the American Thoracic Society, 2020-01, Vol.17 (1), p.16-23

2020

Link zum Volltext

Verfügbarkeit prüfen

Tabby2: a user-friendly web tool for forecasting state-level TB outcomes in the United States

BMC medicine, 2023-08, Vol.21 (1), p.331-331, Article 331

2023

Link zum Volltext

Verfügbarkeit prüfen

Estimated rates of progression to tuberculosis disease for persons infected with Mycobacterium tuberculosis in the United States

Epidemiology (Cambridge, Mass.), 2024-03, Vol.35 (2), p.164

2024

Link zum Volltext

Verfügbarkeit prüfen

Care Cascade for targeted tuberculosis testing and linkage to Care in Homeless Populations in the United States: a meta-analysis

BMC public health, 2018-04, Vol.18 (1), p.485-485, Article 485

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact and Effectiveness of State-Level Tuberculosis Interventions in California, Florida, New York, and Texas: A Model-Based Analysis

American journal of epidemiology, 2019-09, Vol.188 (9), p.1733-1741

2019

Link zum Volltext

Verfügbarkeit prüfen

Disparities in Tuberculosis Incidence by Race and Ethnicity Among the U.S.-Born Population in the United States, 2011 to 2021 : An Analysis of National Disease Registry Data

Annals of internal medicine, 2024-04, Vol.177 (4), p.418

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 655

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(537)
Mit Volltextzugriff
(544)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

Estimated Costs of 4-Month Pulmonary Tuberculosis Treatment Regimen, United States

Rifampin-resistant Tuberculosis in the United States, 1998–2014

State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity

Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007

Treatment of latent Mycobacterium tuberculosis infection with 12 once weekly directly-observed doses of isoniazid and rifapentine among persons experiencing homelessness

Outlook for tuberculosis elimination in California: An individual-based stochastic model

Model-based Analysis of Tuberculosis Genotype Clusters in the United States Reveals High Degree of Heterogeneity in Transmission and State-level Differences Across California, Florida, New York, and Texas

Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model

Healthcare facility-based strategies to improve tuberculosis testing and linkage to care in non-U.S.-born population in the United States: A systematic review

Trends, Mechanisms, and Racial/Ethnic Differences of Tuberculosis Incidence in the US-Born Population Aged 50 Years or Older in the United States

Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis

Yield of community-based tuberculosis targeted testing and treatment in foreign-born populations in the United States: A systematic review

Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model

Eligibility for a Shorter Treatment Regimen for Multidrug-resistant Tuberculosis in the United States, 2011–2016

Comparing Drivers and Dynamics of Tuberculosis in California, Florida, New York, and Texas

Time Since Infection and Risks of Future Disease for Individuals with Mycobacterium tuberculosis Infection in the United States

Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States

Multidrug-Resistant Tuberculosis in Patients with Human Immunodeficiency Virus. Management Considerations within High-resourced Settings

Tabby2: a user-friendly web tool for forecasting state-level TB outcomes in the United States

Estimated rates of progression to tuberculosis disease for persons infected with Mycobacterium tuberculosis in the United States

Care Cascade for targeted tuberculosis testing and linkage to Care in Homeless Populations in the United States: a meta-analysis

Impact and Effectiveness of State-Level Tuberculosis Interventions in California, Florida, New York, and Texas: A Model-Based Analysis

Disparities in Tuberculosis Incidence by Race and Ethnicity Among the U.S.-Born Population in the United States, 2011 to 2021 : An Analysis of National Disease Registry Data

Suchergebnisse filtern